Follow US:
NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer
UC Riverside researchers say ‘molecular crowbar’ strategy is a promising method in drug discovery
$13.7M grant from National Cancer Institute will support several projects on breast and pancreatic cancers
